Subscribe now

New Scientist. Science news and long reads from expert journalists, covering developments in science, technology, health and the environment on the website and the magazine.

.Stop cancer cells dividing, and rule

(Image: Steve Gschmeissner/SPL)

A DRUG that blocks the way cancer cells generate energy could lead to a new class of cancer treatments.

The first human trial of the drug, published this week, is reported to have extended the lives of four people with an aggressive form of brain cancer.

The result is preliminary, but it suggests that, as an approach, tackling “cancer metabolism” is sound. “We are still a long way from a treatment, but this opens the window on drugs that target cancer metabolism,” says Evangelos Michelakis of the University of Alberta

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers


Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop